Daito Pharmaceutical Co.,Ltd.

4577・Prime Market・Pharmaceuticals

Official website

Daito Pharmaceutical Co.,Ltd.

4577・Prime Market・Pharmaceuticals

Official website

Daito Pharmaceutical Co.,Ltd.4577

Reference Indicators

Market Cap

373¥100M

P/E (Forecast)

12.4x

P/B

0.7x

Dividend Yield (Forecast)

3.48%

ROE

6.0%

EV/EBITDA

5.4x

Financial Summary

Unit: ¥M

Item	2022May 2022	2023May 2023	2024May 2024	2025May 2025	2026May 2026
Net Sales	43,464	45,101	46,895	50,643	50,650
Cost of Sales	32,005	34,770	37,056	42,005	40,753
Gross Profit	11,458	10,331	9,839	8,637	9,897
SG&A Expenses	4,905	5,123	5,945	6,017	6,260
Operating Income	6,553	5,207	3,894	2,619	3,637
Non-operating Income	205	86	126	245	424
Non-operating Expenses	29	124	97	160	249
Ordinary Income	6,729	5,169	3,923	2,705	3,812
Extraordinary Income	269	12	461	638	569
Extraordinary Losses	278	105	166	385	316
Pre-tax Income	6,720	5,076	4,218	2,958	4,065
Income Taxes	2,092	1,549	1,040	1,192	928
Net Income	4,668	3,600	3,295	1,908	3,161
EBITDA	9,866	9,077	7,553	6,951	8,024
Gross Margin	26.4%	22.9%	21.0%	17.1%	19.5%
Operating Margin	15.1%	11.5%	8.3%	5.2%	7.2%
ROA	7.2%	5.1%	4.2%	2.4%	4.3%
ROE	10.5%	7.3%	6.4%	3.7%	6.0%